王忻慈 Hsin-Tzu Wang



Biotech/ Clinical Research
Taipei,TW
[email protected]

Education

Chung Shan Medical University, bachelor degree, Department of Biomedical Science, 

2007-2011

National Cheng Kung University, master degree, Department of Physiology, 

2011 ~ 2013

Professional Experience

Medical College in Wisconsin, Department of Medicine, Division of Hematology and Oncology, Project Appointment, Aug 2013 ~ Aug 2014

Attended Dr. Li-Shu Wang's team to investigate the prevention of black raspberries on pancreatic cancer. 

1. Breeding mice to create new models: 

(1) To generate double and triple transgenic mice: Gene mutations of K-ras and p53 in pancreatic model. 

(2) Bioluminescent Orthotopic Model of Pancreatic Cancer: Luciferase-tagged pancreatic cancer cells are resuspended in Matrigel and delivered into the pancreatic tail during laparotomy. 

2. Bioluminescent in vivo imaging system (IVIS): To detect Panc-1-Luc+ cells migration. 

3. Flow cytometer to measure the population/function of immune cells. 

4. Immunohistochemistry of Pancreatic Neoplasia. 

5. Attended American Association for Cancer Research (AACR) in 2014. 

6. Journal presentation and progress report. 

7. Involved in several journals and manuscript publication. 

(1) Black raspberries suppress colonic adenoma development in ApcMin/+ mice: relation to metabolite profiles. Carcinogenesis 2015 Oct;36(10):1245-53. 

(2) Systemic Metabolite Changes in Wild-type C57BL/6 Mice Fed Black Raspberries. Nutr Cancer 2017 Feb-Mar;69 (2):299-306.

(3) Can dietary interventions enhance cancer immunotherapy through manipulating gut microbiota in humans? eFood-2020-0025.

PELLbmt Ltd, Department R&D, Research Associate, Apr 2018 ~ till now

Cell Therapy included engineered patient's immune stem cells to recognize and attack their target cancer cells. 1. Chimeric Antigen Receptor (CAR) T cells 

(1) Before the initiation of the CAR-T therapy, using IHC staining to find the specific target antigen. 

(2) Optimization of manufacturing conditions for CAR-T cells for autologous adoptive immunotherapy. 

(3) I have been used simple approach to transduce primary human T cells with CAR. 

(4) In vitro co-culture method to evaluate cytotoxicity CAR-T with cancer cells. 

2. Adipose-derived Stem Cells 

1. I have used transgenic-modified primary adipose-derived stem cells models to study the mechanism of the cytotoxic of the cancers and cirrhosis. 

2. Flow cytometry, LDH-Glo or Delphia to investigate the potential killing effects of the transgene on the of liver cirrhosis and cancers. 

3. Setup SOP 

4. Apply ADSC proposal to Taiwan Food and Drug Administration (TFDA).

Details Education

Chung Shan Medical University, bachelor degree, Department of Biomedical Science, 2007-2011

Involved in Dr. Shu-Hong Wang's lab for Spinal Muscular Atrophy (SMA) study in 2008. 

1. I built up my strong experimental skills in SHW's lab by training from 8:00-0:00. 

2. Obtained the scholarship in the university  

3. I accomplished simple thesis to include my three years studies. 

4. I went through the Recommendation-Selection Admission Program to National Cheng Kung University as a graduate student.

National Cheng Kung University, master degree, Department of Physiology, 2011 ~ 2013

Involved in Dr. Mei-Ling Tsai's lab for Cardiovascular study in 2011. Dissertation: Activated ERbeta increases the expression of L-type Ca2+ channel and enhances the hypertrophic phenotype of neonatal rat hearts 

1. Had been trained to use English to present and write our proposal and thesis. 

2. Trained medical students in Physiology experiments. 

3. 2012 Presented my studies in the 27th Joint Annual Conference of Biomedical Science. 

4. 2012 Went to Hong Kong for academic exchange with the students in the Chinese University of Hong Kong (CUHK). 

5. 2013 Won Academic Excellence Award for my dissertation.

Experimental skills


Cells

1. Extract cancer pateint's PBMC from whole blood
2. Extract Adipose-derived stem cells from lipid tissue
3. Extract primary cardiac cells from mouse heart
4. Cancer cells: Toledo, SKOV3, MCF7, BxPC3, Panc-1, 293T, LNCaP, Hela
5. Stem cells: ADSCs
6. Immune cells: primary T cells
7. Myoblasts: Sol8, H9c2, C2C12
8. Hepatocyte: HepG2, HA59T/VGH

Animals

1. Transgenic mice mating 

2. Mating: mice/ rats 

3. Ear punch  

4. IV injection 

5. Subcutaneous injection 

6. Intraperitoneal 

7. IVIS system: luciferase assay 

8. Take care of myocardial infarction rat model 

9. Laparotomy

10. Anesthesia: Isoflurane


Tissue

1. HE staining_rat heart model

2. IHC staining: Cancer patient's tumors

3. Toluidine blue O: ADSC differentiate into chondrocyte


Protein

1. Cell and tissue protein extraction 
2. ELISA
3. Western blot

DNA/RNA

1. Extract plasmid DNA
2. Extract RNA
3. PCR
4. Real-Time PCR
5. Transfection_puromycin, electronic
6. Transformation
7. Establish construct

Virus

1. Use fugene as transfection reagent for virus package
2. Use polyject as transfection reagent for virus package
3. Transduce primary T cells
4. Transduce primary ADSCs

Cytotoxicity

1. Flow cytometry
2. Cytotox glo assay
3. LDH assay
4. Delphia assay


Proliferation

1. MTT assay
2. Flow cytometry_cell cycle


Staining

1. Immunoflourescence
2. luciferase assay
3. CFDA staining
4. PI staining
5. Adipose staining: ADSC differentiate into adipocyte

Differentiation

1. Differentiate ADSC into chondrocyte, adipocyte and osteoclast
2. Differentiate C2C12 and Sol8 into skeletal muscle 
3. Differentiate H9c2 into skeletal or cardiomyocyte-like cells